Hind Medyouf

Hind Medyouf is an EMBO young investigator working at the Institute for Tumor Biology and Experimental Therapy (Georg-Speyer-Haus), in Frankfurt, Germany. Hind trained as a PhD at the Curie Institute (France; 2003-2007) followed by two postdocs as an EMBO and HFSP fellow in Canada (Terry Fox Lab; 2008-2010) and Germany (DKFZ; 2010-2014), respectively. As a trainee, she built a strong expertise and track record in the pathophysiological mechanisms driving hematological malignancies and their exploitation for therapeutic purposes. In 2014, Hind obtained an ERC starting grant and established her research group in Germany, where she is pursuing research questions centered around the importance of the tumor microenvironment in hematological malignancies and metastasis. Her current work focuses on (1) the mechanisms underlying niche co-option and immune evasion, as well as (2) the contribution of age-related niche changes to cancer progression.